Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Influence of AMPK Subunit Alpha (PRKAA2) Genetic Polymorphisms With Susceptibility to Chinese Type 2 Diabetes Mellitus and Diabetic Nephropathy

NCT03155087 is registered in ClinicalTrials.gov with People's Hospital of Zhengzhou University as lead sponsor.

NCT NCT03155087
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03155087 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Influence of AMPK Subunit Alpha (PRKAA2) Genetic Polymorphisms With Susceptibility to Chinese Type 2 Diabetes Mellitus and Diabetic Nephropathy
Lead sponsor
People's Hospital of Zhengzhou University
Phase
Observational
Overall status
Completed
Start date
June 30, 2013
Completion date
December 31, 2015
Enrollment
750 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

t2dm (type 2 diabetes mellitus)